USPTO serial 79164797
Serial No. 79164797
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 29, 2016
- Examiner
- MAI, TINA HSIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79164797?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Limited Liability Company "NEARMEDIC PLUS"
RU
Other trademarks owned by Limited Liability Company "NEARMEDIC PLUS"
Limited Liability Company "NEARMEDIC PLUS"
RU
Other trademarks owned by Limited Liability Company "NEARMEDIC PLUS"
Limited Liability Company "NEARMEDIC PLUS"
RU
Other trademarks owned by Limited Liability Company "NEARMEDIC PLUS"
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Max Vern
Max Vern Amster, Rothstein & Ebenstein LLP90 Park AvenueNew York, NY 10016UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry; chemicals used in science; carbonic hydrates; raw materials, namely, animal or vegetable albumin for industrial use; raw material, namely, animal albumen for industrial use; chemicals for use in industry, namely, cellulose derivatives; chemical reagents, other than for medical or veterinary purposes; stem cells other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations including cell-based preparations for medical purposes including stem cells for the treatment of endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; biocides; biological preparations for the prevention and treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; medicines for use by humans, namely, for use in the treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; albuminous preparations for medical purposes, namely, for use in the treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; stem cells for medical purposes; surgical dressings; diagnostic preparations for medical purposes; chemical preparations for medical purposes, namely, for use in the treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; biological tissue cultures for medical purposes; cell implants made of living tissue | SECTION 71 - CANCELLED | — |
| 010 | Medical apparatus and instruments for treating cardiovascular, infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases; testing apparatus for medical purposes in the field of cancer, hepatology, ophthalmology, gastroenterology, hematology, dermatology, neurology, immunology, and infectious diseases; suture materials; surgical thread; surgical implants comprised of artificial materials; surgical cell implants comprised of natural, non-living materials; surgical implants consisting primarily of artificial materials and also including biological materials | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Limited Liability Company "NEARMEDIC PLUS"
- Other trademarks owned by Limited Liability Company "NEARMEDIC PLUS"
- Other trademarks owned by Limited Liability Company "NEARMEDIC PLUS"
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 29, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Aug 29, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Apr 1, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 1, 2024 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 1, 2024 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jun 14, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 14, 2022 | C71T | CANCELLED SECTION 71 | — |
| Mar 29, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 23, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 1, 2016 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jun 30, 2016 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jun 29, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 29, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 15, 2016 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 12, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 12, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 28, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 24, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 23, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 7, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 30, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 30, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 30, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 30, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 30, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 24, 2015 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 27, 2015 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 14, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 9, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 9, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 9, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 9, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 9, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 26, 2015 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 26, 2015 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 26, 2015 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 20, 2015 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 4, 2015 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 21, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 21, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jul 17, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 17, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 8, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 1, 2015 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 1, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 1, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 1, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 7, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 20, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 20, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 20, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 19, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 19, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 18, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| May 15, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 14, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |